What is Crizotinib?

Category: Prescription Drugs

Most popular types: Xalkori

false

Crizotinib is an orally administered product that may be used for the treatment of metastatic non-small cell lung cancer that is positive for anaplastic lymphoma kinase (ALK).

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Adenocarcinoma (non-small cell lung cancer) 80 13
Non-small cell lung cancer 13 2
Lung cancer 9 0
Adenosquamous carcinoma (non-small cell lung cancer) 7 2
Squamous cell carcinoma (non-small cell lung cancer) 2 0
Atypical lung carcinoid tumor 1 0

Show all 8 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 5
Mild 8
None 1

Commonly reported side effects and conditions associated with Crizotinib

Side effect Patients Percentage
Diarrhea 3
Fatigue 2
Fluid retention (edema) 2
Nausea 2
Blurry vision 1
Cardiac arrest 1

Show all 16 reported side effects

Dosages

Based on patients currently taking Crizotinib

Dosage Patients Percentage
250 mg twice daily 2
1 capsule(s) twice daily 1

Why patients stopped taking Crizotinib

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 5
Doctor's advice 4
Side effects too severe 2
See all 8 patients who've stopped taking Crizotinib

Duration

Currently taking Crizotinib

Duration Patients Percentage
2 - 5 years 2
5 - 10 years 1

Stopped taking Crizotinib

Duration Patients Percentage
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 1
2 - 5 years 4
Adherence
Adherence Evaluations Percentage
Always 14
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 15
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 1
< $25 5
Not specified 9

What people switch to and from

Patients started taking Crizotinib after stopping:

Treatment Patients Percentage
Chemotherapy 3
Alectinib (Alecensa) 1
Pemetrexed (Alimta) 1

Patients stopped taking Crizotinib and switched to:

Treatment Patients Percentage
Alectinib (Alecensa) 9
Ceritinib (Zykadia) 3
Last updated:
There are no evaluations for Crizotinib.